India is participating in the NeoSep1 clinical trial, which aims to improve treatment for drug-resistant newborn sepsis using ...

Jipmer becomes the first Indian center to enroll an infant in the NeoSep1 trial, targeting neonatal sepsis and antimicrobial resistance.

Flosonics Medical received the Paul and Debra Walker Award, part of the Sepsis Research and Innovation Challenge at the Unite for Sepsis Symposium presented by Sepsis Alliance in Washington, D.C. on ...

India has enrolled its first newborn in the global NeoSep1 trial at JIPMER, Puducherry. The study will test antibiotic ...

The Integrated Assessment Tool assesses aged care needs to determine eligibility for government-supported aged care services.

Will AI replace healthcare jobs? Not exactly. Learn which roles face the greatest disruption, which remain resilient, and how ...

The Global Antibiotic Research and Development Partnership (GARDP) said yesterday that an international clinical trial ...

TikTok creates purchase urgency faster than any review process can keep up with — and the only honest way to find out whether ...

Several Twin Cities beaches are temporarily closed due to Escherichia coli, also known as E. coli, according to city and ...

The NeoSep1 trial is expected to enroll 3,000 newborns across Asia and Africa by the end of 2028. ​Along with India, newborns ...

The federal government has quietly launched a rapid review into a controversial algorithm after older Australians sound the ...

The first step to understanding AI’s real potential is turning down the volume on the people who are selling it most loudly.